Shenzhen Xintian Technology Co., Ltd. (Stock Code: 300615)
Announcement No.: 2026-020
The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
In accordance with the "Enterprise Accounting Standards" and the relevant provisions of Shenzhen Xintian Technology Co., Ltd.'s accounting policies, and adhering to the principle of prudence, the company conducted impairment tests on assets within the scope of the consolidated financial statements as of December 31, 2025, which may show signs of impairment. Based on the results of these tests, the company reversed previously recognized asset and credit impairment provisions. The specific situation is as follows:
I. Overview of the Provision for Asset Impairment
(1) Reasons for the Provision of Asset Impairment
In accordance with the "Enterprise Accounting Standards" and the company's accounting policies, to accurately reflect the company's financial condition, asset value, and operating results, and adhering to the principle of prudence, the company conducted impairment tests on various assets within the scope of the consolidated financial statements as of December 31, 2025, and recognized impairment provisions for assets expected to incur impairment losses.
(2) Scope and Total Amount of Asset Impairment Provision
The company conducted impairment tests on assets that may show signs of impairment as of December 31, 2025. Based on the results of these tests, the company recognized a total asset impairment loss of 37.4325 million yuan, detailed as follows:
| Category | Item | Amount (10,000 yuan) |
|---|---|---|
| Credit Impairment Loss | Bad debt loss on notes receivable | -2.98 |
| Bad debt loss on accounts receivable | 226.12 | |
| Bad debt loss on other receivables | -113.32 | |
| Subtotal | 109.82 | |
| Asset Impairment Loss | Long-term equity investment impairment loss | -3,853.34 |
| Inventory write-down and contract performance cost impairment loss | 0.27 | |
| Subtotal | -3,853.07 | |
| Total | -3,743.25 |